Longitudinal surveillance of kelch13 mutations associated with artemisinin resistance in Western Kenya

Domaine:

healthcare

Type de record:

dataset

Créateur:

Ken

Éditeur:

Ken

Éditeur:

Har

Hôte:

These FASTA files contain sequence data from a study on antimalarial drug resistance markers in Kenya 2023. Key points: - Study Focus: Genetic diversity of ama1, k13, dhps, dhfr and mdr1 genes in malaria parasites. - Kenyan counties. - Sequencing Method: Targeted Amplicon Deep Sequencing (TADs) of nested PCR products. Pf K13 codon 469 and 675

Emergence of Genetic Mutations associated with Malaria Diagnostic and Artemisinin Partial Resistance in Somalia: A Genomic Surveillance Study

Histidine-rich protein 2 (HRP2)-based rapid diagnostic tests (RDTs) are central to malaria case mana

Molecular surveillance for artemisinin resistance in Africa Molecular surveillance for artemisinin resistance in Africa.

International audience

Plasmodium falciparum non-synonymous Kelch13 mutations mediating artemisinin resistance in East Africa: A systematic review and meta-analysis: 2014–2024

Background Resistance to antimalarial drugs has posed a significant challenge

Rising prevalence of Plasmodium falciparum Artemisinin partial resistance mutations in Ethiopia

Background Ethiopia aims to eliminate local malaria transmission by 2030, but rising malaria case

Identification of Mutations in Antimalarial Resistance Gene Kelch13 from Plasmodium falciparum Isolates in Kano, Nigeria

Malaria control relies on first-line treatments that use artemisinin-combination therapies (ACT). Un

Molecular surveillance for polymorphisms associated with artemisinin-based combination therapy resistance in Plasmodium falciparum isolates collected in Mozambique, 2018

Abstract Background Due to the threat of emerging anti-malarial

Longitudinal surveillance of kelch13 mutations associated with artemisinin resistance in Western Kenya

Domaine:

Type de record:

Visit

Tags

Licenses